
Alkyl Amines Q2 FY27: PAT +52% YoY as margins expand, but cools 31% QoQ off Q1 peak
Alkyl Amines' standalone PAT came in at ₹65.17 Cr on revenue from operations of ₹490.95 Cr for the September 2026 quarter. Year-on-year — the primary read — revenue grew 26.1% (₹389.41 Cr) and PAT grew a faster 51.8% (₹42.94 Cr), with net margin expanding to 13.0% from 10.8% and operating margin to 19.9% from 18.0%. Sequentially the print is softer: revenue fell 7.0% and PAT fell 31.1% against Q1 FY27 (revenue ₹528.01 Cr, PAT ₹94.63 Cr, OPM 25.3%), but Q1 was itself an exceptionally strong base — the company had flagged PAT +91% YoY and margin expansion to 25.3% that quarter — so the QoQ dip reads as reversion rather than fresh deterioration; no exceptional items appear in any of the compared quarters. The margin bridge sits mostly on operating leverage: cost of materials consumed eased to 53.1% of revenue from operations (versus 59.9% in Q1 and 49.2% a year ago), but employee costs (₹33.95 Cr) and other expenses (₹90.16 Cr) held roughly flat in absolute terms versus Q1 (₹36.31 Cr and ₹90.05 Cr), so the 7% QoQ revenue decline compressed operating margin from Q1's elevated 25.3% to 19.9% — still above the year-ago 18.0%. Tax worked out to ₹24.92 Cr on PBT of ₹90.09 Cr (effective rate 27.7%), in line with recent quarters. No public analyst consensus for this quarter turned up in search, so vs-street is unknown rather than assumed. Against management's own May 2026 concall guidance — 5-10% volume growth for the year, revenue significantly higher on elevated prices, and margins bottoming out with room to improve — this print is broadly on-track: YoY revenue and margin both moved in the guided direction, though the QoQ pullback means the margin recovery is not yet linear. No management press release commentary was available in the context to cross-check against. Separately, the stock saw a trading-volume spike in early October that drew a BSE clarification request (company confirmed no undisclosed price-sensitive information) — unrelated to this result. On the balance sheet, the company drew ₹19 Cr of secured borrowings for the first time in recent periods and capital work-in-progress rose to ₹159.53 Cr from ₹130.48 Cr, with H1 FY27 capex of ₹36.72 Cr tracking within the ₹80-90 Cr full-year guided band.
Key Highlights
- Revenue from operations ₹490.95 Cr: +26.1% YoY (₹389.41 Cr) but -7.0% QoQ (₹528.01 Cr in Q1 FY27).
- PAT ₹65.17 Cr: +51.8% YoY (₹42.94 Cr) but -31.1% QoQ off Q1 FY27's ₹94.63 Cr, which was itself a +91% YoY print.
- Operating margin 19.9% vs 18.0% a year ago (expansion) but down from Q1's 25.3%; net margin 13.0% vs 10.8% YoY, down from Q1's 17.6%.
- No exceptional items in this or comparison quarters; PBT ₹90.09 Cr, tax ₹24.92 Cr (27.7% effective rate), reconciling cleanly to PAT.
- Company drew ₹19 Cr of secured borrowings and capital work-in-progress rose to ₹159.53 Cr from ₹130.48 Cr as expansion projects continue; H1 FY27 capex ₹36.72 Cr vs ₹80-90 Cr full-year guidance.
- EPS (basic) ₹12.74 for the quarter, down from ₹18.50 in Q1 FY27, up from ₹8.40 a year ago.
Price Impact
More from ALKYLAMINE